Acute hallucinosis due to clonidine

Area of Science:

• Neuroscience
• Pharmacology
• Clinical Medicine

Background:

• Hypertension is a prevalent cardiovascular condition requiring pharmacotherapy.
• Clonidine is an alpha-2 adrenergic agonist commonly prescribed for hypertension.
• Adverse drug reactions can significantly impact patient management and outcomes.

Observation:

• A 54-year-old male patient presented with acute hallucinosis.
• The patient was undergoing treatment for hypertension with clonidine.
• A prior episode of similar symptoms was noted, which resolved after discontinuing clonidine.

Findings:

• A direct correlation was observed between clonidine administration and the onset of acute hallucinosis.
• Discontinuation of clonidine led to the complete resolution of hallucinatory symptoms.
• This case highlights a potential adverse effect of clonidine therapy.

Implications:

• Clinicians should be vigilant for psychiatric side effects, such as hallucinosis, in patients treated with clonidine.
• This case underscores the importance of thorough medication history review in diagnosing drug-induced adverse events.
• Further investigation into the neurobiological mechanisms underlying clonidine-induced hallucinosis may be warranted.